degussa said planned for five rights issue 225 marks per share raising nominal share capital mln marks end its current business year ending september company said statement would also raise nominal share capital mln marks share swap part its planned takeover french medicine group two capital measures will raise degussa nominal share capital 365 mln marks degussa said last week intended buy 100 pct capital medical pharmaceuticals group sarget based merignac near bordeaux sarget had 1986 sales france belgium netherlands spain portugal and italy 730 mln french francs degussa has not said how much would pay for sarget but mln marks nominal mark shares today frankfurt opening price 494 marks would worth nearly 198 mln marks mln mark nominal capital increase 225 marks would raise 274 mln marks degussa said mln mark nominal capital increase would form issue shares for cash consideration april annual meeting agreed would rights issue this capital which was already authorized but unissued rights issue involving mln mark nominal capital increase will led dresdner bank following capital increase degussa would left with mln marks authorized but unissued capital degussa spokesman said part 274 mln marks from rights issue would also used for serget acquisition added reuter 